- Home
- NBIX vs AGI Comparison
NBIX vs AGI Comparison
Compare NBIX & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- AGI
- Stock Information
- Founded
- NBIX 1992
- AGI 2003
- Country
- NBIX United States
- AGI Canada
- Employees
- NBIX N/A
- AGI N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- AGI Precious Metals
- Sector
- NBIX Health Care
- AGI Basic Materials
- Exchange
- NBIX Nasdaq
- AGI Nasdaq
- Market Cap
- NBIX 14.1B
- AGI 13.5B
- IPO Year
- NBIX 1996
- AGI 1999
- Fundamental
- Price
- NBIX $139.41
- AGI $31.51
- Analyst Decision
- NBIX Strong Buy
- AGI Buy
- Analyst Count
- NBIX 18
- AGI 4
- Target Price
- NBIX $161.50
- AGI $30.38
- AVG Volume (30 Days)
- NBIX 713.3K
- AGI 3.3M
- Earning Date
- NBIX 10-29-2025
- AGI 11-05-2025
- Dividend Yield
- NBIX N/A
- AGI 0.30%
- EPS Growth
- NBIX 2.97
- AGI 63.27
- EPS
- NBIX 3.39
- AGI 0.82
- Revenue
- NBIX $2,509,900,000.00
- AGI $1,507,900,000.00
- Revenue This Year
- NBIX $20.66
- AGI $39.21
- Revenue Next Year
- NBIX $14.64
- AGI $15.84
- P/E Ratio
- NBIX $41.44
- AGI $40.94
- Revenue Growth
- NBIX 18.42
- AGI 34.51
- 52 Week Low
- NBIX $84.23
- AGI $17.43
- 52 Week High
- NBIX $154.61
- AGI $34.01
- Technical
- Relative Strength Index (RSI)
- NBIX 53.05
- AGI 59.32
- Support Level
- NBIX $140.56
- AGI $32.57
- Resistance Level
- NBIX $144.04
- AGI $34.01
- Average True Range (ATR)
- NBIX 3.54
- AGI 0.90
- MACD
- NBIX -0.26
- AGI 0.03
- Stochastic Oscillator
- NBIX 35.85
- AGI 52.70
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.